Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000279653 refers to an uncharacterized transcript (AC004678.2) that is provisionally associated with the TEC gene in some genomic databases[1][7]. There is no evidence that this entry represents a canonical protein-coding gene, receptor, enzyme, or other recognized therapeutic target[1][7]. Common genomic databases do not provide functional annotation, disease association, or therapeutic interaction for this transcript, and there is ambiguity about whether it reflects a real biological entity or a computational artifact[1][7][5]. No molecular function, biological process, or family classification is assigned, and there are no known drugs or safety concerns relevant to this entry. Correction and context: - The term “ENSG00000279653” is an Ensembl identifier that maps to a transcript called *AC004678.2*, and is sometimes crosslisted with *TEC*, a tyrosine kinase gene. However, no authoritative source lists ENSG00000279653 itself as the coding gene for TEC tyrosine kinase or any well-defined protein; TEC is a distinct, characterized gene (typically ENSG00000187971 for human TEC)[1][7]. - Functional, disease, and drug-related information pertain to TEC protein, not to the uncharacterized transcript ENSG00000279653[1][7]. - Most structured and curated databases classify ENSG00000279653 as "Uncategorized" with missing protein function, family, or clinical information[1]. Summary: - ENSG00000279653 is not considered a therapeutic target and likely represents a non-coding transcript or database artifact, not a canonical drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on AC004678.2.